GlassScriptPhysician profile
George D Weiss
NPI 1679614408
$11,689.88
in general payments reported to CMS, 2019-2025
18 companies · $408 in 2025
The $408 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $771 · 2020: $2,446 · 2021: $2,708 · 2022: $4,192 · 2023: $534 · 2024: $630 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,572.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Standard Bariatrics, INC. | $5,758.84 | 2020-2022 | |
| Baxter Healthcare | $3,340.04 | 2019-2025 | Tisseel, Floseal |
| Intuitive Surgical, INC. | $768.14 | 2019-2025 | |
| Covidien LP | $699.34 | 2019-2020 | |
| Medtronic, INC. | $277.79 | 2021-2023 | Appose Ulc |
| Tela Bio, INC. | $170.43 | 2021-2022 | |
| Teleflex LLC | $162.82 | 2024-2025 | Titan Sgs Bailout Chuck, Titan Sgs |
| Davol INC. | $128.69 | 2021 | |
| Ethicon US, LLC | $75.47 | 2021 | |
| Gt Metabolic Solutions INC | $68.34 | 2025 | |
| Lilly USA, LLC | $47.17 | 2024-2025 | Zepbound |
| Novo Nordisk INC | $37.79 | 2020-2024 | Wegovy |
| Eagle Pharmaceuticals, INC. | $34.14 | 2022-2023 | |
| Acacia Pharma INC | $34.05 | 2022 | |
| Edwards Lifesciences Corporation | $28.18 | 2023 | Hemosphere |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $26.55 | 2025 | |
| Chiesi USA, INC. | $19.94 | 2023 | Cleviprex |
| Conmed Corporation | $12.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.